Brainsway (BWAY) Research & Development (2025 - 2026)

Brainsway posted quarterly Research & Development of $2.9 million for Q1 2026, up 23.54% year-on-year from $2.3 million in Q1 2025, and up 23.54% on a QoQ basis from $2.3 million in Q1 2025.

Brainsway (BWAY) has 2 years of Research & Development data on file, last reported at $2.9 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 767.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 413.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 722.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 516.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 263.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -461.27 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 145.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 345.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.80 Mn
10 Brainsway 6.80 Mn -52.98 Mn 11.68 Mn 2.88 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.88 Mn
Mar 31, 2025 2.33 Mn